BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, May 14, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 2, 2007
View Archived Issues
New experimental and clinical data on lacosamide presented
Read More
Novel agents for treating endocrine-associated disorders disclosed in recent patent literature
Read More
Recent patents disclose new therapeutic agents for neurological disorders
Read More
VGX signs DNA vaccines license agreement with U. of Pennsylvania
Read More
Kyowa Hakko Kogyo licenses Japanese and Asian rights to ARQ-197
Read More
SciClone acquires rights in U.S. and Canada to RP-101
Read More
Elan reviews quarterly progress
Read More
New phase II trial for Avugane in acne vulgaris
Read More
York Pharma acquires Rosanto
Read More
Acropolis reports on PA-105, an antiangiogenic agent with antiprostate cancer activity
Read More
EMEA will not approve Cerepro at this time
Read More
Meda acquires product portfolio from Wyeth
Read More
Enrollment completed in phase I/II study of BDM-E for diabetic macular edema
Read More
E.U. positive opinion for PegIntron and Rebetol for HCV in HIV subjects
Read More
VR-004 achieves erectile dysfunction endpoints in phase IIb trial
Read More
CDC25 phosphatase inhibition with IRC-083864 suppresses tumor growth in vitro and in vivo
Read More
CDK inhibitor SNS-032 induces apoptosis in multiple myeloma cells
Read More
GSK-461364, a potent, selective small-molecule PLK1 inhibitor selected for further development
Read More
Acceptable safety profile emerges from early clinical trial with masitinib
Read More
Tolvaptan improves patient-reported health outcomes in hyponatremic patients
Read More
Sebivo receives E.U. approval
Read More
Approval for once-daily Veramyst nasal spray
Read More
Invega approved for long-term maintenance treatment of schizophrenia
Read More
Soliris recommended for European approval in PNH
Read More
FDA approves AzaSite for bacterial conjunctivitis
Read More
Recent Gedeon Richter and Glenmark patents disclose novel analgesic agents
Read More
Telavancin filed for European approval for cSSTI
Read More